<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02299609</url>
  </required_header>
  <id_info>
    <org_study_id>CCTSAU1400</org_study_id>
    <nct_id>NCT02299609</nct_id>
  </id_info>
  <brief_title>Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI</brief_title>
  <official_title>Therapeutic Effect of Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sakarya University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sakarya University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Successfully perfused STEMI patients will receive routine transthoracic echocardiography qid
      for 4 days or placebo. Myocardial function and infarct size will be evaluated at 3 and 6
      months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who had acute STEMI and successfully reperfused by either thrombolytic therapy or
      primary angioplasty and stenting will be included this study.

      A basal routine echocardiography will be obtained in all patients after reperfusion therapy.
      Thereafter, patients will be divided into two groups: 1.Treatment group will receive
      transthoracic echocardiography using Philips HD11 XE ® for 30 minutes qid for 4 days. 2.
      Placebo group will have the same Philips HD11 XE ® echo transducer applied for the same time
      and duration on their chest but with the ultrasound turned-off. Detailed left and right
      ventricle function as well as performance index and stress-strain imaging will be obtained
      and analyzed at 3 and 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase in left ventricular function</measure>
    <time_frame>At 3 and 6 months</time_frame>
    <description>Ultrasound beams during echocardiography application expected to ameliorate the left ventricle function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decrease in infarct size</measure>
    <time_frame>At 3 and 6 months</time_frame>
    <description>Ultrasound beams during echocardiography application expected to decrease infarct size</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>ST Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Beam Receiver</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Philips HD11 XE® 30 min qid x 4 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beam Non-Receiver</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Philips HD11 XE® (ultrasound turned-off) 30 min qid x 4 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound beams Philips HD11 XE®</intervention_name>
    <description>Ultrasound beams used during standard echocardiography</description>
    <arm_group_label>Beam Receiver</arm_group_label>
    <arm_group_label>Beam Non-Receiver</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        -Patients presenting within 12 hours of their first ST- elevation myocardial infarction
        that is successfully reperfused; and completed baseline echocardiographic evaluation and
        accepted participation in the study

        Exclusion criteria:

        Patients:

          -  With prior ST- elevation myocardial infarction

          -  Patients presenting &gt;12hrs

          -  Not successfully reperfused

          -  Not completed baseline ECHO evaluation,

          -  Not accepting participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ramazan Akdemir, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sakarya University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ramazan Akdemir, MD</last_name>
    <phone>00905336020700</phone>
    <email>rakdemir@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ramazan Akdemir, MD</last_name>
    <phone>00905426427388</phone>
    <email>ramazanakdemir@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sakarya University, Faculty of Medicine</name>
      <address>
        <city>Sakarya</city>
        <zip>54290</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramazan Akdemir, MD</last_name>
      <phone>00905336020700</phone>
      <email>rakdemir@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Ling ZY, Shu SY, Zhong SG, Luo J, Su L, Liu ZZ, Lan XB, Yuan GB, Zheng YY, Ran HT, Wang ZG, Yin YH. Ultrasound targeted microbubble destruction promotes angiogenesis and heart function by inducing myocardial microenvironment change. Ultrasound Med Biol. 2013 Nov;39(11):2001-10. doi: 10.1016/j.ultrasmedbio.2013.06.003. Epub 2013 Aug 19.</citation>
    <PMID>23969167</PMID>
  </results_reference>
  <results_reference>
    <citation>Nazer B, Gerstenfeld EP, Hata A, Crum LA, Matula TJ. Cardiovascular applications of therapeutic ultrasound. J Interv Card Electrophysiol. 2014 Apr;39(3):287-94. doi: 10.1007/s10840-013-9845-z. Epub 2013 Dec 3. Review.</citation>
    <PMID>24297498</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2014</study_first_submitted>
  <study_first_submitted_qc>November 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>November 21, 2014</last_update_submitted>
  <last_update_submitted_qc>November 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sakarya University</investigator_affiliation>
    <investigator_full_name>Ramazan Akdemir</investigator_full_name>
    <investigator_title>Prof. Ramazan Akdemir, MD</investigator_title>
  </responsible_party>
  <keyword>C14.280.647.500</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

